187 related articles for article (PubMed ID: 5260856)
1. [Chronic myelogenous leukemia. Results of therapy with busulfan].
Olesen J; Videbaek A
Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
[No Abstract] [Full Text] [Related]
2. [Ambulatory treatment of patients with chronic myeloid leukemia].
Lobanova NA
Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
[No Abstract] [Full Text] [Related]
3. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
Ionescu V
Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
[No Abstract] [Full Text] [Related]
4. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
Sullivan JR; Hurley TH; Bolton JH
Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
[TBL] [Abstract][Full Text] [Related]
5. Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.
Das KV; Thomas M; Pilla MV; Vijayakumar
J Assoc Physicians India; 1977 Aug; 25(8):547-53. PubMed ID: 275251
[No Abstract] [Full Text] [Related]
6. [Clinical effects of Vercyte(A-803) on chronic myelogenous leukemia].
Kinugasa K; Takaku F; Sasa S; Mizoguchi H; Komine M
Naika; 1971; 28(1):151-6. PubMed ID: 5284419
[No Abstract] [Full Text] [Related]
7. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
Ferrara F; Palmieri S; Annunziata M; Viola A; Pocali B; Califano C; D'Arco AM; Mele G
Bone Marrow Transplant; 2004 Oct; 34(7):573-6. PubMed ID: 15258559
[TBL] [Abstract][Full Text] [Related]
8. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
Galton DA
Haematol Lat; 1969; 12(3):703-9. PubMed ID: 5273182
[No Abstract] [Full Text] [Related]
9. [Treatment of chronic myeloid leukemia with dibromomannitol].
Clément F; Saillen R
Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
[No Abstract] [Full Text] [Related]
10. [Therapy of the blastic crisis].
Tura S; Baccarani M; Bagnara GP
Minerva Med; 1972 Mar; 63(24):1459-67. PubMed ID: 4502509
[No Abstract] [Full Text] [Related]
11. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
Larrain C; Cruz A; Codoceo V
Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
[No Abstract] [Full Text] [Related]
13. [Differential diagnosis of atypical chronic myeloid leukaemia].
Klein UE; Schwarze EW; Schwalbe P; Tolksdorf ME
Dtsch Med Wochenschr; 1976 Jun; 101(24):915-20. PubMed ID: 1064523
[TBL] [Abstract][Full Text] [Related]
14. [Remarks on the course and prognostic factors in a series of chronic myeloid leukemia].
Furno F; Neretto G; Mazza A; Giovanelli E; Agricola R; Martinetto P
Arch Sci Med (Torino); 1980; 137(3):499-506. PubMed ID: 6940518
[No Abstract] [Full Text] [Related]
15. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Martino R; Pérez-Simón JA; Moreno E; Queraltó JM; Caballero D; Mateos M; Sureda A; Cañizo C; Brunet S; Briones J; Vazquez L; Clopés A; San Miguel JF; Sierra J
Biol Blood Marrow Transplant; 2005 Jun; 11(6):437-47. PubMed ID: 15931632
[TBL] [Abstract][Full Text] [Related]
16. [On the tactics of myelosan therapy of chronic myeloleukosis].
Kassirskiĭ IA; Volkova MA
Ter Arkh; 1967 Feb; 39(2):3-9. PubMed ID: 5252300
[No Abstract] [Full Text] [Related]
17. [Pulmonary fibrosis after busulfan therapy].
Jandl H; Franke A; Albrecht G
Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
[TBL] [Abstract][Full Text] [Related]
18. [Clinical conference: Thrombocythemic introduction to chronic myeloid leukemia].
Bauters F; Goudemand M
Nouv Rev Fr Hematol; 1975; 15(2):241-4. PubMed ID: 126433
[No Abstract] [Full Text] [Related]
19. [Aplastic syndrome in myleran overdose].
Albrecht M; Tackmann W; Pribilla W
Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287
[No Abstract] [Full Text] [Related]
20. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
Szentcsíki M; Brenner F; Balogh C; Hites L
Orv Hetil; 1982 May; 123(21):1307-8. PubMed ID: 6955735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
